Transversalis Fascia Plane Block and Rectus Sheath Block in Renal Transplantation Donors
- Conditions
- Postoperative Pain
- Interventions
- Procedure: Transversalis fascia plane block and rectus sheath blockDevice: Intravenous fentanyl patient control device
- Registration Number
- NCT05324215
- Lead Sponsor
- Koc University Hospital
- Brief Summary
Transversalis fascia plane block (TFPB) is a relatively new, easy-to-apply and safe regional anesthesia technique used to provide postoperative analgesia in various surgeries. It has been shown that TFPB and rectus sheath block (RSB) administration reduces opioid consumption and related side effects in patients undergoing surgery with general anesthesia. To our knowledge, there is no study examining TFPB in donor nephrectomy.
The investigators aimed to prospectively examine the effect of TFPB and RSB on opioid consumption in postoperative period on donors who will undergo laparoscopic nephrectomy in renal transplantation surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 50
- Donor patients scheduled for elective nephrectomy in renal transplantation surgery
- American Society of Anesthesiologists (ASA) I-II
- Patients who are aged between 18-75
- Skin infection at the block area
- Coagulation disorder and using anticoagulant drugs
- End-stage organ and system failure
- Severe pulmonary and/or cardiovascular problems
- Substance addiction or known psychiatric or mental problems
- Chronic painkiller usage
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Transversalis Fascia Plane Block and Rectus Sheath Block Group Transversalis fascia plane block and rectus sheath block Transversalis Fascia Plane Block and Rectus Sheath Block will be administered to this group. Transversalis Fascia Plane Block and Rectus Sheath Block Group Intravenous fentanyl patient control device Transversalis Fascia Plane Block and Rectus Sheath Block will be administered to this group. Control Group Intravenous fentanyl patient control device No regional anesthesia technique will be applied to the control group.
- Primary Outcome Measures
Name Time Method Total opioid consumption retrieved from patient records up to 24 hours the amount of fentanyl required by the patient and given by the device will be recorded for the first 24 hours.
- Secondary Outcome Measures
Name Time Method Numeric Rating Scale (NRS) up to 24 hours Pain of patients will be evaluated and recorded according to NRS. A NRS requires the patient to rate their pain on a defined scale between 0 and10 (0 is no pain and 10 is the worst pain)
Trial Locations
- Locations (1)
Koç University Hospital
🇹🇷Istanbul, Zeytinburnu, Turkey